TABLE 7.
Pearson’s correlation analysis between MD and neuropsychological test.
| MD | SCC | GCC | PIC | LN | CR | CS |
| MMSE | −0.314* | −0.357** | −0.378** | – | −0.370** | −0.479** |
| MoCA | – | −0.418** | −0.307* | – | −0.361** | −0.477** |
| HDSR | −0.262* | −0.397** | −0.396** | – | −0.391** | −0.488** |
| CDR | – | 0.298* | 0.333** | – | 0.347** | 0.512** |
| DST | −0.254* | −0.500** | – | – | – | −0.341** |
| VFT | – | −0.515** | – | – | −0.385** | −0.401** |
| FAB | – | −0.350** | −0.325* | – | −0.381** | −0.433** |
| TMTA | – | 0.356** | 0.358** | 0.434** | – | 0.362** |
| RAVLT immediate | −0.281* | −0.383** | −0.299* | – | −0.499** | −0.549** |
| RAVLT short | −0.273* | −0.382** | – | – | −0.473** | −0.516** |
| RAVLT long | – | −0.385** | – | – | −0.483** | −0.489** |
| RAVLT recognition | – | −0.446** | −0.271* | – | −0.467** | −0.480** |
| NPI-Q1 | – | – | – | 0.319* | 0.326* | – |
| NPI-Q2 | – | – | – | 0.281* | 0.306* | – |
| HAMA | – | 0.394** | – | – | – | – |
| HAMD | – | 0.401** | – | – | – | – |
| ADL | – | – | – | – | 0.380** | 0.381** |
MD, mean diffusion; SCC, splenium of corpus callosum; GCC, genu of corpus callosum; PIC, posterior limb of internal capsule; LN, lenticular nucleus; CR, corona radiate; CS, centrum semiovale; MMSE, mini-mental state examination; MoCA, Montreal cognitive assessment scale; HDSR, Hasegawa dementia scale revised; CDR, clinical dementia rating scale; DST digit span test; VFT, verbal fluency test; FAB, frontal assessment battery; TMTA, trail making test A; RAVLT, Rey auditory verbal learning test (immediate recall/short-term delayed recall/long-term delayed recall/recognition); NPI-Q, neuropsychiatric inventory-questionnaire (NPI-Q1: the score of patient, NPI-Q2: the score of caregiver); HAMA, Hamilton anxiety scale; HAMD, Hamilton depression scale; ADL, activity of daily living scale. *p < 0.05, **p < 0.01. Bold data (0.6–0.8), indicating high-intensity correlation.